ReviewTherapeutic advances in endocrinology and metabolism2025
Using digital tools to improve diabetes care in India with continuous glucose monitoring.
Review in Therapeutic advances in endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Optimizing Continuous Glucose Monitoring Adoption in India: From Current Challenges to Future Solutions.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Continuous glucose monitoring (CGM) has revolutionized diabetes management globally, offering real-time insights into blood glucose levels and trends. In India, where diabetes prevalence is significant, the adoption of digital health tools (DHTs) for CGM has seen remarkable growth. However, successful integration and adoption of these DHTs require collaboration between healthcare professionals and individuals with diabetes. Ensuring the compatibility, accuracy, and reliability of CGM systems is imperative for optimizing diabetes management outcomes in India. Several challenges persist in adopting DHTs for CGM in the country. The adoption of ambulatory glucose profiles and CGM using DHTs has been transformative in diabetes clinics. This paper culminates with expert recommendations on integrating DHTs into diabetes clinics, focusing on training, communication, and technology utilization. The introduction of the Freestyle
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.